Lao People's Democratic Republic vs Nigeria: Share of S. aureus infections resistant to methicillin
Lao People's Democratic Republic
55.9%
in 2022
Nigeria
65.1%
in 2022
Lao People's Democratic Republic rank
6th
Nigeria rank
4th
Share of S. aureus infections resistant to methicillin over time
- Lao People's Democratic Republic
- Nigeria
How they compare
Nigeria currently reports 65.1% against 55.9% in Lao People's Democratic Republic, a difference of 9.2%.
That makes Nigeria's figure about 1.2 times Lao People's Democratic Republic's.
Across all 5 years both countries report, Nigeria has been ahead every year.
Lao People's Democratic Republic ranks 6th and Nigeria ranks 4th of 45 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.4% | 64.3% | 53.8% | Nigeria |
| 2020s | 45.3% | 69.1% | 23.8% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Lao People's Democratic Republic or Nigeria?
- Nigeria, at 65.1% against 55.9% in Lao People's Democratic Republic as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Lao People's Democratic Republic and Nigeria?
- 9.2%, with Nigeria ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Nigeria?
- 5 years are reported by both, from 2017 to 2022.
- How do Lao People's Democratic Republic and Nigeria rank globally for share of s. aureus infections resistant to methicillin?
- Lao People's Democratic Republic ranks 6th and Nigeria ranks 4th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).